SGLT2 Inhibitors for Diabetes May Protect Against AKI, Increase UTI Risk

With increasing use of sodium glucose cotransporter 2 (SGLT2) inhibitors, investigators are taking a closer look at potential adverse events.

Related Keywords

Germany ,Australia ,Japan ,United States ,Kaseda ,Kagoshima ,Massachusetts ,Boston ,South Korea ,Japanese ,American ,Korea ,Brian Chiang ,Mitsuboshi Satoru ,Bonggi Kim ,Jan Menne ,Korean National Health Insurance Service ,Flinders Medical Centre ,International Journal Of Cardiology ,Pharmacology Research Perspectives ,Hannover Medical School In ,Korea Institute Of Drug Safety ,Harvard Medical School ,Hannover Medical School ,American Journal ,Kidney Disease ,Elisabetta Patorno ,Event Reporting System ,Kaetsu Hospital ,Medical Data Vision ,Korea Institute ,Drug Safety ,Risk Management ,Pharmacology Research ,International Journal ,Pharmacol Res ,